未登录

C

Chansey J. Veinotte

Dalhousie University

H指数:10

被引数:890

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases

IF3.5

2019-12-2010

OAAI

High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma

CLINICAL CANCER RESEARCH

IF10.2

2019-07-1531

OAAI

Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9 (vol 46, e102, 2018)

NUCLEIC ACIDS RESEARCH

IF13.1

2018-07-2412

OAAI

Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9

NUCLEIC ACIDS RESEARCH

IF13.1

2018-06-1462

OAAI

In Vivo Validation ofPAPSS1(3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target

CLINICAL CANCER RESEARCH

IF10.2

2017-10-3113

OAAI

High-throughput chemical screening identifies Focal Adhesion Kinase and Aurora Kinase B inhibition as a synergistic treatment combination in Ewing sarcoma

CANCER RESEARCH

IF16.6

2017-07-011

PRE

PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) inhibition sensitizes non-small cell lung cancer to cisplatin treatment in vivo

CANCER RESEARCH

IF16.6

2016-07-152

PRE

Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia

IF7.9

2014-10-0386

OAAI

Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era

DISEASE MODELS & MECHANISMS

IF3.3

2014-07-01155

OAAI

Using zebrafish xenotransplantation to study the role of Y-Box binding protein (YB-1) in the metastasis of Ewing family tumors

CANCER RESEARCH

IF16.6

2012-04-010

PRE